Atlas Trials

Ranolazine Implantable Cardioverter-Defibrillator Trial

Clinical trial NCT01215253 · COMPLETED

Trial details

NCT number
NCT01215253
Sponsor
University of Rochester
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Ischemic CardiomyopathyNonischemic CardiomyopathyHeart Failure
Start date
2011-09-01
Primary completion
2017-02-28
Enrollment
1012

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.